Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
Monday, May 18 is HIV Vaccine Advocacy Day. Support science. Not sound bites.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
An $80,000 grant from The Campbell Foundation will help scientist Natalia Freund continue her HIV vaccine studies.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
Promising news on the prevention front
The Phase IIb/III HVTN 702 trial will begin enrollment in southern Africa in the fall.
The International AIDS Vaccine Initiative (IAVI) marks 20 years in the search for an end to the epidemic.
The International AIDS Vaccine Initiative (IAVI) is collaborating with NineSigma, one of the world’s topmost innovation service providers, to...
Initiatives launched aimed at sparking a resurgence of interest and commitment to finding a safe and effective vaccine for HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.